MARKET

YTEN

YTEN

Yield10
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.22
-0.46
-5.99%
Closed 16:00 07/29 EDT
OPEN
7.68
PREV CLOSE
7.68
HIGH
7.68
LOW
7.17
VOLUME
38.87K
TURNOVER
--
52 WEEK HIGH
23.49
52 WEEK LOW
4.160
MARKET CAP
35.15M
P/E (TTM)
-2.2747
1D
5D
1M
3M
1Y
5Y
Yield10 Bioscience Begins 2021 Field Test And Seed Scale Up Program
Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company, today announced it has completed planting of its 2021 Field Test and Seed Scale Up program at all contracted sites in the United States, Canada,
Benzinga · 07/13 12:41
Yield10 Bioscience Completes Planting of 2021 Field Test and Seed Scale Up Program
MT Newswires · 07/13 11:50
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
Benzinga · 07/12 20:38
Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients
Today Pionyr Immunotherapeutics, Inc., a company developing first-in-class antibody therapeutics that increase the body's anti-tumor immunity and Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life science reagents and tools, announced the extensio...
PR Newswire · 06/22 12:00
Looking Into Yield10 Bioscience's Return On Capital Employed
Yield10 Bioscience (NASDAQ:YTEN) reported Q1 sales of $196.00 thousand. Earnings fell to a loss of $2.55 million, resulting in a 2.22% decrease from last quarter. Yield10 Bioscience collected $195.00 thousand in revenue during Q4, but reported earnings sho...
Benzinga · 06/18 14:20
Yield10 Bioscience To Present On Advances Using Camelina Platform To Produce PHA Bioplastic At 2021 Synthetic Biology Virtual Conference
Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the 2021 Synthetic Biology: Engineering, Evolution &
Benzinga · 06/16 12:35
Yield10 Bioscience Files For U.S. Patent Titled 'GENES AND GENE COMBINATIONS FOR ENHANCED CORN PERFORMANCE'
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220210139924%22.PGNR.&OS=DN/20210139924&RS=DN/202
Benzinga · 05/13 16:01
Schedule For Benzinga's Global Small Cap Conference Thursday, May 13, 2021
Check out the full agenda via Benzinga's Events page: https://www.benzinga.com/events/small-cap/global/#agenda * the list below is limited to some of the publicly-traded companies that will be presenting
Check out the full agenda via Benzinga's Events page:  * the list below is limited to some of the publicly-traded companies that will be presenting · 05/13 13:08
More
Forecast
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of YTEN. Analyze the recent business situations of Yield10 through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average YTEN stock price target is 25.33 with a high estimate of 27.00 and a low estimate of 24.00.
EPS
Institutional Holdings
Institutions: 29
Institutional Holdings: 1.28M
% Owned: 26.27%
Shares Outstanding: 4.87M
TypeInstitutionsShares
Increased
6
230.46K
New
11
753.56K
Decreased
1
5.80K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.49%
Pharmaceuticals & Medical Research
-0.31%
Key Executives
Chairman/Director
Robert Van Nostrand
President/Chief Executive Officer/Director
Oliver Peoples
Chief Accounting Officer/Vice President - Finance
Charles Haaser
Vice President
Lynne Brum
Vice President
Kristi Snell
General Counsel/Secretary
Sarah Cecil
Other
Tichafa Munyikwa
Other
Nicholas Renegar
Director
Sherri Brown
Director
Richard Hamilton
Director
Joseph Shaulson
Independent Director
Anthony Sinskey
No Data
About YTEN
Yield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn. The Company concentrates on technologies that enables it to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter. The Company has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada.

Webull offers kinds of Yield10 Bioscience Inc stock information, including NASDAQ:YTEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, YTEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading YTEN stock methods without spending real money on the virtual paper trading platform.